Conference Coverage

Here to talk about current concepts in the management of osteoporosis like insurance coverage, therapy sequencing, and comparative effectiveness is Dr. Michael Lewiecki, who presented a session on this exact topic at the 2024 Congress of Clinical Rheumatology.

The United States has seen its largest increase in syphilis cases in the past five years. And with increases prevalent in every region, along with a shortage of medication, additional surveillance strategies and importation resources are necessary. Dive in for a discussion on the challenges and strategies to combat the spread of syphilis with Dr. Ina Park, Professor of Family Community Medicine at the University of California San Francisco School of Medicine.

According to recent data, nutrition plans like the Mediterranean, DASH, and MIND diets can help patients with a variety of neurological diseases, including multiple sclerosis, stroke, and dementia. Tune in to hear Dr. Karima Benameur discuss this research and how we can counsel patients with neurological diseases about nutrition. Dr. Karima Benameur is an Associate Professor of Neurology at Emory University who presented a session on this topic at the 2024 American Academy of Neurology Annual Meeting.

Children who have neurological disorders and experience pain are often not able to articulate how their pain affects them. That’s why it’s important for clinicians to understand the brain’s role in the experience of pain and how to help these patients and their families navigate their pain. Joining Dr. Charles Turck to share best practices for counseling and treating pain in children with neurological disorders are Drs. Lauren Treat and Wendy Gaultney, who presented a session on this topic at the 2024 American Academy of Neurology Annual Meeting.

Daily oral therapy can have low adherence, which is why the field of long-acting formulations is rapidly advancing. Tune in to hear Dr. Charles Flexner discuss how long-acting regimens can address this problem of adherence and help patients living with HIV, tuberculosis, malaria, and other infectious diseases. Dr. Flexner is a Professor of Medicine of Pharmacology, Molecular Sciences, and International Health at Johns Hopkins University, and he also presented a session on this exact topic at the 2024 Conference on Retroviruses and Opportunistic Infections.

Climate change can have devastating effects on neurologic infections. One study suggested that the more population-dense urban areas are, the more likely several infections can be transmitted between humans. So what can be done to reduce this risk? Tune in with Dr. Monica Maria Diaz, Assistant Professor of Neurology at the University of North Carolina School of Medicine. This is also the topic of her session at the 2024 American Academy of Neurology Annual Meeting.

Many complications can occur in hospitalized neurological patients from an internal medicine standpoint. So a session from the 2024 Academy of American Neurology (AAN) Annual Meeting focused on these common issues, how they can be addressed quickly, and the role of a neurohospitalist. Dive in further with Dr. Erick Tarula, Assistant Professor in the Department of Neurology at the University of Wisconsin School of Medicine and Public Health.

Stroke is one of the leading causes of death in pregnancy in the United States, underscoring the importance of knowing the causes, risks, and treatment of stroke in pregnancy and postpartum. That’s why Dr. Eliza Miller is here to share key insights from her session at the 2024 AAN Annual Meeting that focused on this exact topic. Dr. Miller is an Associate Professor of Neurology in the Division of Stroke and Cerebrovascular Disease at Columbia University.

Medical gaslighting refers to the situation where a medical professional disregards an individual's health concerns. It most often affects patients suffering from neurological disorders like long COVID and MS, and it can be extremely damaging to the physician-patient relationship. This underscores the importance of knowing how to recognize and reduce medical gaslighting in clinical practice, which is why Dr. Michele Longo is here to discuss the “Healing Doubt: Confronting and Overcoming Medical Gaslighting” session she presented at the 2024 AAN Annual Meeting.

Cognitive rehabilitation in patients with multiple sclerosis started about 20 to 25 years ago when it transitioned from predominantly patients with traumatic brain injury to other patient populations including multiple sclerosis. And over that period of time, the number of studies that have examined the efficacy of cognitive rehabilitation in MS has grown substantially. However, gaps remain and further research is needed. Dive into to learn more about cognitive rehabilitation trials for MS with Dr. Nancy Chiaravalloti, Director of the Center for Neuropsychology and Neuroscience Research and the Center for Traumatic Brain Injury Research at Kessler Foundation, who also presented a session on this topic at the ACTRIMS 2024 Forum.